do glp-1 agonists have cardiovascular benefit Bridging the gap between GLP1-receptor and outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology do glp 1 agonists have
Description
A., Fallatah, J
SUSTAIN 7 investigators
The introduction of highly efficacious and generally safe medications for obesity treatment, such as GLP-1RAs, has disrupted this framework, reframing obesity as a medical issue that can be treated pharmacologically
Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1 options
The second cause for concern stemming from an increased use is patients access
